Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

patient expectations

- PMLiVE

GSK to acquire Bellus Health for approximately $2bn

The deal includes the biotech’s late-stage candidate for refractory chronic cough

- PMLiVE

FDA approves Gamida’s cell therapy for blood cancer patients

Blood cancers represent about 10% of all annual US cancer cases

- PMLiVE

Authorisation for Moderna and Pfizer/BioNTech’s bivalent COVID-19 vaccines simplified by FDA

The vaccines are now authorised for all doses in individuals aged six months and older

- PMLiVE

Tiziana to develop intranasal foralumab for type 1 diabetes

Approximately 4.7 million people in the UK are currently living with diabetes

- PMLiVE

Four simple questions to help focus your behaviour change campaigns

By Samuel Hughes and Edward Brightman

- PMLiVE

Global healthcare consultancy Uptake Strategies unveils a newly refreshed identity

Uptake, formerly known as Uptake Strategies, has revealed a bold brand refresh for its 18th year

- PMLiVE

AstraZeneca presents positive phase 3 results for Imfinzi regimen in lung cancer

Around 2.2 million people are diagnosed with lung cancer globally each year

- PMLiVE

Gilead’s COVID-19 treatment shows promising results in vulnerable patient populations

Veklury demonstrated a reduction in mortality and hospital readmission rates

- PMLiVE

Roche reports positive phase 3 data for Tecentriq combination in liver cancer

More than 900,000 people are diagnosed with the disease globally each year

- PMLiVE

Shionogi’s cefiderocol shows efficacy against difficult-to-treat bacterial infections

Antimicrobial resistance has been declared as one of the top ten threats to global health

- PMLiVE

How to deal with HCPs’ change in preferences after the pandemic

By Darren Talbot (pictured right) and Dirk Szynka (pictured left)

- PMLiVE

Merck to acquire Prometheus Biosciences for almost $11bn

The deal includes the biotech’s lead candidate for ulcerative colitis and Crohn's disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links